Tumor cell-derived EVs stimulate MMP-9, IL-6, and transforming growth factor-β (TGF-β) and induce the secretion of EMMPRIN, which, in the tumor microenvironment, drives immune evasion, invasion, and inflammation that promote tumorigenesis [93]. The gene discussed is IL6; the disease is neoplasm.